Secretoglobin expression in ovarian carcinoma: Lipophilin B gene upregulation as an independent marker of better prognosis

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Bignotti, Eliana ^a   Tassi, Renata A ^a   Calza, Stefano ^a,b   Ravaggi, Antonella ^a   Rossi, Elisa ^c   Donzelli, Carla ^a   Todeschini, Paola ^a   Romani, Chiara ^a   Bandiera, Elisabetta ^a   Zanotti, Laura ^a   Carnazza, Mario ^a   Quadraro, Francesco ^a   Tognon, Germana ^a   Sartori, Enrico ^a   Pecorelli, Sergio ^a   Roque, Dana M ^d   Santin, Alessandro D ^d  

^a UNIVERSITY OF BRESCIA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Gene expression; Lipophilin B; Ovarian carcinoma; Prognosis; Secretoglobins

Indexed keywords

CARBOPLATIN; FORMALDEHYDE; GEMCITABINE; HIGH IN NORMAL 1 PROTEIN; INTERFERON GAMMA INDUCIBLE SECRETOGLOBIN; LIGAND BINDING PROTEIN RYD5; LIPOPHILIN A; LIPOPHILIN B; MAMMAGLOBIN A; MESSENGER RNA; PACLITAXEL; PARAFFIN; PLATINUM COMPLEX; SECRETOGLOBIN; TOPOTECAN; UNCLASSIFIED DRUG; UTEROGLOBIN; UTEROGLOBIN RELATED PROTEIN 1;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE FREE SURVIVAL; EMBEDDING; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GYNECOLOGICAL EXAMINATION; HIN 1 GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IIS GENE; IMMUNOHISTOCHEMISTRY; LIPOPHILIN A GENE; LIPOPHILIN B GENE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MAMMAGLOBIN A GENE; OMENTECTOMY; OVARY BIOPSY; OVARY CARCINOMA; OVERALL SURVIVAL; PHENOTYPE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RYD5 GENE; SALPINGOOOPHORECTOMY; TISSUE FIXATION; TUMOR CELL; UGRP 1 GENE; UPREGULATION; UTEROGLOBIN GENE;

AGED; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PHENOTYPE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SECRETOGLOBINS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84879820289     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-162     Document Type: Article

References (42)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013, S0959-8049(13):00007-5. [Epub ahead of print].
2. DiSaia PJ, Creasman WT. Epithelial ovarian cancer 2002, 185-206. St. Louis: Mosby -Year Book, Inc, Clinical gynecologic oncology.
3. Berman ML. Future directions in the surgical management of ovarian cancer. Gynecol Oncol 2003, 90(2 Pt 2):S33-S39.
4. Klug J, Beier HM, Bernard A, et al. Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci 2000, 923:348-354.
5. Ni J, Kalff-Suske M, Gentz R, et al. All human genes of the uteroglobin family are localized on chromosome 11q12.2 And form a dense cluster. Ann N Y Acad Sci 2000, 923:25-42.
6. Krop IE, Sgroi D, Porter DA, et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci USA 2001, 98(17):9796-9801. 10.1073/pnas.171138398, 55532, 11481438.
7. Niimi T, Keck-Waggoner CL, Popescu NC, et al. UGRP1, A uteroglobin/Clara cell secretory protein-related protein, is a novel lung-enriched downstream target gene for the T/EBP/NKX2.1 Homeodomain transcription factor. Mol Endocrinol 2001, 15(11):2021-2036. 10.1210/me.15.11.2021, 11682631.
8. Watson MA, Fleming TP. Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 1994, 54(17):4598-4602.
9. Becker RM, Darrow C, Zimonjic DB, et al. Identification of mammaglobin B, a novel member of the uteroglobin gene family. Genomics 1998, 54(1):70-78. 10.1006/geno.1998.5539, 9806831.
10. Mukherjee AB, Kundu GC, Mantile-Selvaggi G, et al. Uteroglobin: a novel cytokine?. Cell Mol Life Sci 1999, 55(5):771-787. 10.1007/s000180050331, 10379362.
11. Sjödin A, Guo D, Hofer PA, et al. Mammaglobin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol 2003, 121(2):428-429. 10.1046/j.1523-1747.2003.12374.x, 12880439.
12. Sjödin A, Guo D, Sørhaug S, et al. Dysregulated secretoglobin expression in human lung cancers. Lung Cancer 2003, 41(1):49-56. 10.1016/S0169-5002(03)00126-0, 12826312.
13. Tachihara-Yoshikawa M, Ishida T, Watanabe K, et al. Expression of secretoglobin3A2 (SCGB3A2) in primary pulmonary carcinomas. Fukushima J Med Sci 2008, 54(2):61-72. 2743607, 19418968.
14. Kurotani R, Kumaki N, Naizhen X, et al. Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans. Lung Cancer 2011, J71(1):42-48.
15. Sjödin A, Guo D, Lund-Johansen M, et al. Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas. Acta Neuropathol 2005, 109(4):381-386. 10.1007/s00401-004-0972-6, 15668787.
16. Culleton J, O'Brien N, Ryan BM, et al. Lipophilin B: a gene preferentially expressed in breast tissue and upregulated in breast cancer. Int J Cancer 2007, 120(5):1087-1092.
17. Sjödin A, Ljuslinder I, Henriksson R, et al. Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation. Anticancer Res 2008, 28(3A):1493-1498.
18. Zafrakas M, Petschke B, Donner A, et al. Expression analysis of mammaglobin a (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies. BMC Cancer 2006, 6:88-100. 10.1186/1471-2407-6-88, 1513245, 16603086.
19. Tassi RA, Bignotti E, Falchetti M, et al. Mammaglobin B expression in human endometrial cancer. Int J Gynecol Cancer 2008, 18(5):1090-1096. 10.1111/j.1525-1438.2007.01137.x, 18021217.
20. Onuma K, Dabbs DJ, Bhargava R. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium. Int J Gynecol Pathol 2008, 27(3):418-425. 10.1097/PGP.0b013e31815d05ec, 18580321.
21. Bignotti E, Tassi RA, Calza S, et al. Differential gene expression profiles between tumor biopsies and short term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 2006, 103(2):405-416. 10.1016/j.ygyno.2006.03.056, 16725184.
22. Tassi RA, Bignotti E, Rossi E, et al. Overexpression of mammaglobin B in epithelial ovarian carcinomas. Gynecol Oncol 2007, 105(3):578-585. 10.1016/j.ygyno.2007.01.043, 17343903.
23. Tassi RA, Calza S, Ravaggi A, et al. Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence. BMC Cancer 2009, 9:253-264. 10.1186/1471-2407-9-253, 2724548, 19635143.
24. Jackson BC, Thompson DC, Wright MW, et al. Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse scgb gene superfamily. Hum Genomics 2011, 5(6):691-702. 10.1186/1479-7364-5-6-691, 3251818,3251818, 22155607.
25. O'Brien N, Maguire TM, O'Donnovan N, et al. Mammaglobin a: a promising marker for breast cancer. Clin Chem 2002, 48:1362-1364.
26. Lehrer RI, Xu G, Abduragimov A, et al. Lipophilin, a novel heterodimeric protein of human tears. FEBS Lett 1998, 432:163-167. 10.1016/S0014-5793(98)00852-7, 9720917.
27. Colpitts TL, Billing-Mendel P, Friedman P, et al. Mammaglobin is found in breast tissue as a complex with BU101. Biochem 2001, 40:11048-11059.
28. Li J, Fadare O, Xiang L, Kong B, Zheng W. Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol 2012, 5:8. 10.1186/1756-8722-5-8, 3328281, 22405464.
29. Auersperg N. Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?. Gynecol Oncol 2013, 130:246-51. 10.1016/j.ygyno.2013.03.021, 23558054.
30. Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G, Nikitin AY. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 2013, 495(7440):241-5. 10.1038/nature11979, 23467088.
31. Krop I, Player A, Tablante A, et al. Frequent HIN-1 promoter methylation and lack of expression in multiple human cancer types. Mol Cancer Res 2004, 2:489-94.
32. Weeraratna AT, Cajigas JA, Schwartz A, et al. Loss of uteroglobin expression in prostate cancer: relationship to advancing grade. Clin Cancer Res 1997, 3(12 Pt 1):2295-2300.
33. Marchetti A, Barassi F, Martella C, et al. Downregulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Clin Cancer Res 2004, 10:1338-43. 10.1158/1078-0432.CCR-1174-03, 14977834.
34. Akervall JA, Jin Y, Wennerberg JP, et al. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 1995, 76(5):853-9. 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6, 8625189.
35. Shuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes-a review. Cancer 1995, 159(1):83-96.
36. Carter D, Douglass JF, Cornellison CD, et al. Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochem 2002, 41:6714-22.
37. Sjödin A, Ljuslinder I, Henriksson R, et al. Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation. Anticancer Res 2008, 28:1493-8.
38. Tucker JM, Lipatova Z, Beljanski V, et al. Evaluation of lipophilins as determinants of tumor cell response to estramustine. J Pharmacol Exp Ther 2005, 315(3):1158-62. 10.1124/jpet.105.090860, 16120813.
39. Carter D, Dillon DC, Reynolds LD, et al. Serum antibodies to lipophilin B detected in late-stage breast cancer patients. Clin Cancer Research 2003, 9:749-54.
40. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002, 1(4):304-13. 10.1074/mcp.M200008-MCP200, 12096112.
41. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003, 4(9):117. 10.1186/gb-2003-4-9-117, 193646, 12952525.
42. Tian Q, Stepaniants SB, Mao M, et al. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Proteomics 2004, 3(10):960-9. 10.1074/mcp.M400055-MCP200, 15238602.